Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ernexa Therapeutics Inc. M&A Activity 2021

Feb 3, 2021

35259_rns_2021-02-04_28ab37e7-5dd3-4280-8c18-fbf7e5139138.zip

M&A Activity

Open in viewer

Opens in your device viewer

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 3, 2021

NTN BUZZTIME, INC.

(Exact name of registrant as specified in charter)

Delaware 001-11460 31-1103425
(State
or other jurisdiction of incorporation) (Commission File
Number) (I.R.S.
Employer Identification
No.)

| 6965
El Camino Real, Suite 105-Box 517 | |
| --- | --- |
| Carlsbad,
California | 92009 |
| (Address
of principal executive offices) | (Zip
Code) |

(760) 438-7400

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

| [X] | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| [ ] | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock | NTN | NYSE
American |

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.[ ]

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 8.01 Other Events.

On February 3, 2021, NTN Buzztime, Inc. (“NTN”) issued a press release announcing, among other matters, that it set the date for its special meeting at which its stockholders will be asked to approve proposals related to the proposed merger involving NTN and Brooklyn ImmunoTherapeutics LLC and the proposed sale of NTN’s assets to eGames.com Holdings LLC. A copy of the press release is attached as an exhibit to this report and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

| Exhibit
No. | Description |
| --- | --- |
| 99.1 | Press release dated February 3, 2021 |

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/
Sandra Gurrola |
| --- |
| Sandra
Gurrola |
| Sr.
Vice President of Finance |

Field: Page; Sequence: 3; Options: Last

Field: /Page